This Week at FDA: Califf faces House Oversight committee, diversity plans on the horizon, and more

This Week at FDAThis Week at FDADiagnostics/IVDsDigital health/SaMD/AIGenericsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States